Tower Research Capital LLC (Trc) Rani Therapeutics Holdings, Inc. Transaction History

Tower Research Capital LLC (Trc)

  • $3.39 Billion
  • Q3 2025

A detailed history of Tower Research Capital LLC (Trc) transactions in Rani Therapeutics Holdings, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 6,224 shares of RANI stock, worth $12,074. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,224
Previous 9,285 32.97%
Holding current value
$12,074
Previous $4,000 25.0%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
$0.41 - $0.7 $1,255 - $2,142
-3,061 Reduced 32.97%
6,224 $3,000
Q2 2025

Aug 14, 2025
BUY
$0.48 - $1.39 $4,456 - $12,906
9,285 New
9,285 $4,000
Q3 2024

Nov 14, 2024
SELL
$2.06 - $3.99 $26,194 - $50,736
-12,716 Reduced 88.08%
1,721 $3,000
Q2 2024

Aug 13, 2024
BUY
$3.13 - $7.85 $41,309 - $103,604
13,198 Added 1065.21%
14,437 $54,000
Q1 2024

May 15, 2024
SELL
$2.98 - $3.8 $3,185 - $4,062
-1,069 Reduced 46.32%
1,239 $3,000
Q4 2023

Feb 13, 2024
BUY
$1.85 - $3.67 $4,269 - $8,470
2,308 New
2,308 $7,000
Q2 2023

Aug 14, 2023
BUY
$3.92 - $5.58 $12,587 - $17,917
3,211 Added 83.69%
7,048 $29,000
Q1 2023

May 09, 2023
BUY
$5.07 - $6.89 $6,743 - $9,163
1,330 Added 53.05%
3,837 $20,000
Q4 2022

Feb 10, 2023
BUY
$5.51 - $10.02 $6,220 - $11,312
1,129 Added 81.93%
2,507 $15,000
Q3 2022

Nov 10, 2022
SELL
$8.23 - $12.4 $1,687 - $2,542
-205 Reduced 12.95%
1,378 $13,000
Q2 2022

Aug 15, 2022
BUY
$8.0 - $14.25 $8,360 - $14,891
1,045 Added 194.24%
1,583 $16,000
Q1 2022

May 12, 2022
SELL
$12.21 - $23.14 $25,738 - $48,779
-2,108 Reduced 79.67%
538 $7,000
Q4 2021

Feb 14, 2022
BUY
$16.09 - $35.0 $42,574 - $92,610
2,646 New
2,646 $43,000

Others Institutions Holding RANI

# of Institutions
41
Shares Held
3.84M
Call Options Held
0
Put Options Held
0
View Full List

About Rani Therapeutics Holdings, Inc.

RANI Quotes by TradingView
  • Ticker RANI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,492,000
  • Market Cap $47.5M
  • Description
  • Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...
More about RANI
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email